Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Tuesday, 04'th Mar 2025
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Top 50 High-Quality Dividend Stocks For March 2025
12:42am, Tuesday, 04'th Mar 2025
I track 50 high-quality dividend stocks, updating their valuations daily to identify Strong Buy, Buy, Hold, and Trim opportunities based on historical free cash flow trends. Today, I will highlight 9
Laekna Announces IND Approval of LAE120 (a Novel USP1 Inhibitor) for Treatment of Advanced Solid Tumors by FDA
09:30pm, Monday, 03'rd Mar 2025
LOS ANGELES--(BUSINESS WIRE)-- #Biotech--Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the t
Two stocks to make you a millionaire by 2030
08:58am, Monday, 03'rd Mar 2025
By adopting the right investment strategy, the stock market offers numerous opportunities for building wealth, especially when the right equities are involved.
Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe
06:50am, Monday, 03'rd Mar 2025
The CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.
Where Will Eli Lilly Be in 5 Years?
03:39pm, Sunday, 02'nd Mar 2025
It's hard to argue with the kinds of results Eli Lilly (LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares leaving
Eli Lilly takes aim at weight-loss drug copies with new ad campaign
10:05am, Friday, 28'th Feb 2025
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its latest attempt to fend off competition from copies of its weight-loss drug.
Lilly to participate in Leerink Partners Global Healthcare Conference
10:00am, Friday, 28'th Feb 2025
INDIANAPOLIS , Feb. 28, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Leerink Partners Global Healthcare Conference on March 10, 2025. Lucas Montarce, Lilly executive vic
The positive opinion is based on results from the Phase 3 BRUIN CLL-321 trial, recently presented at the 2024 American Society of Hematology Annual Meeting BRUIN CLL-321 is the first randomized Phas
Eli Lilly investing $27B more in US manufacturing
11:41am, Thursday, 27'th Feb 2025
Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest investment is to the tune of $27 billion.
Eli Lilly plans to invest $27B to build four new US plants as tariffs loom
04:06pm, Wednesday, 26'th Feb 2025
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 construction workers.
Committee Stocks on the Move: Lowe's, TJX Companies, Eli Lilly and the XLV
02:00pm, Wednesday, 26'th Feb 2025
The Investment Committee discuss some of their stocks that are moving today.
Eli Lilly Latest US Company to Commit to Domestic Investments
01:56pm, Wednesday, 26'th Feb 2025
Eli Lilly (LLY) plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the U.S., as the company looks to ramp up its domestic drug productions amid the threat of
Eli Lilly announces $27B investment in US drug manufacturing
12:36pm, Wednesday, 26'th Feb 2025
Eli Lilly and Co (NYSE:LLY) plans to invest at least $27 billion in four new US manufacturing facilities, the company announced during an event in Washington DC. Three of the facilities will focus on
Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites
11:53am, Wednesday, 26'th Feb 2025
Eli Lilly & Co.'s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
